Nationwide Trial of Diovan for Patients Suffering Heart Failure To Be Launched in 2005

Norvatis Korea announced it will launch a nationwide clinical studies of Diovan, an angiotensin receptor blocker (ARB) based anti-hypertension drug, for the treatment of patients suffering heart failure (HF).

The nationwide studies will be based on Valsartan Heart Failure Trial (Val-HeFT), deemed to be one of largest worldwide HF trials done to date, where investigators evaluated the effects...